SILVESTRI, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.309
EU - Europa 7.708
AS - Asia 4.582
SA - Sud America 725
AF - Africa 152
OC - Oceania 53
Continente sconosciuto - Info sul continente non disponibili 2
Totale 23.531
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.157
RU - Federazione Russa 2.548
IT - Italia 1.585
PL - Polonia 1.311
SG - Singapore 1.241
CN - Cina 1.122
HK - Hong Kong 698
IE - Irlanda 580
BR - Brasile 572
VN - Vietnam 524
SE - Svezia 405
KR - Corea 349
FR - Francia 286
FI - Finlandia 249
DE - Germania 230
GB - Regno Unito 176
IN - India 158
JO - Giordania 98
CA - Canada 93
BD - Bangladesh 89
CH - Svizzera 83
ID - Indonesia 55
AR - Argentina 53
JP - Giappone 52
AU - Australia 51
ES - Italia 49
AT - Austria 45
TR - Turchia 40
CI - Costa d'Avorio 38
UA - Ucraina 35
ZA - Sudafrica 35
NL - Olanda 34
EC - Ecuador 33
MX - Messico 33
MA - Marocco 32
IQ - Iraq 30
BE - Belgio 24
PK - Pakistan 19
VE - Venezuela 15
SA - Arabia Saudita 14
CO - Colombia 13
IR - Iran 12
PY - Paraguay 12
CL - Cile 10
UZ - Uzbekistan 10
CZ - Repubblica Ceca 8
LT - Lituania 8
AL - Albania 7
NG - Nigeria 7
PE - Perù 7
TN - Tunisia 7
DZ - Algeria 6
KE - Kenya 6
KZ - Kazakistan 6
NP - Nepal 6
RO - Romania 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
BJ - Benin 5
EG - Egitto 5
JM - Giamaica 5
PH - Filippine 5
CR - Costa Rica 4
GT - Guatemala 4
HR - Croazia 4
HU - Ungheria 4
IL - Israele 4
PS - Palestinian Territory 4
TW - Taiwan 4
AM - Armenia 3
AZ - Azerbaigian 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
GR - Grecia 3
HN - Honduras 3
KG - Kirghizistan 3
KH - Cambogia 3
LB - Libano 3
MD - Moldavia 3
MM - Myanmar 3
MU - Mauritius 3
PA - Panama 3
PT - Portogallo 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
EE - Estonia 2
EU - Europa 2
GE - Georgia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LV - Lettonia 2
MC - Monaco 2
MY - Malesia 2
NZ - Nuova Zelanda 2
OM - Oman 2
QA - Qatar 2
RS - Serbia 2
SI - Slovenia 2
Totale 23.507
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.104
Ashburn 1.370
Warsaw 1.305
Fairfield 861
Singapore 859
Hong Kong 589
Dublin 577
Chandler 459
Woodbridge 376
San Jose 347
Seoul 347
Houston 336
Seattle 332
Cambridge 310
Beijing 281
Milan 279
Wilmington 232
Florence 226
Lawrence 178
New York 167
Buffalo 165
Los Angeles 165
Hefei 164
Ho Chi Minh City 158
Altamura 156
Helsinki 140
Princeton 136
Munich 129
Ann Arbor 126
Paris 121
Boston 112
Lauterbourg 110
Moscow 110
Hanoi 108
Dallas 105
Rome 104
The Dalles 102
Mumbai 83
Council Bluffs 82
Bern 77
Turku 65
Shanghai 63
San Diego 60
Clifton 59
Boardman 58
São Paulo 50
Melbourne 48
Kent 47
Medford 46
Tokyo 42
Vienna 42
Jakarta 41
London 39
Abidjan 38
Dong Ket 36
Orem 35
Guangzhou 34
Bologna 31
Da Nang 30
Frankfurt am Main 30
Falls Church 29
Naples 29
Norwalk 29
Toronto 29
Chicago 28
Redondo Beach 28
Turin 28
Barcelona 27
Chennai 27
Montreal 27
Phoenix 27
Johannesburg 26
Rio de Janeiro 26
Brooklyn 24
Casablanca 23
Brussels 21
Palermo 19
Tianjin 19
Denver 18
Figino 18
Hillsboro 18
Stockholm 18
Biên Hòa 17
Haiphong 17
Genoa 16
Jacksonville 16
Manchester 16
Atlanta 14
Baghdad 14
Redwood City 14
Washington 14
Amsterdam 13
Bari 13
Barnet 13
City of London 13
Miano 13
Shenzhen 13
Venice 13
Belo Horizonte 12
Dearborn 12
Totale 15.673
Salva come PNG Salva come JPEG
Nome #
Behçet's syndrome patients exhibit specific microbiome signature. 509
An approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions. 357
Long-term efficacy and safety of anakinra in a patient with Behçet's disease and concomitant tuberculosis infection 335
Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside 313
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 302
SIRT1 activity is decreased in lesional psoriatic skin 295
T cells in gastric cancer: friends or foes. 273
Neutrophil Activation Promotes Fibrinogen Oxidation and Thrombus Formation in Behçet’s Disease 271
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 269
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study. 264
Repeated low-dose courses of rituximab in SLE-associated antiphospholipid syndrome: Data from a tertiary dedicated centre 262
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 260
Digital ulcers secondary to Sneddon's syndrome successfully treated with Bosentan: not only useful in Systemic Sclerosis 252
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 245
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 236
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 230
Brief Report: Rituximab for the treatment of adult-onset IgA vasculitis (Henoch-Schönlein purpura) 224
Intravenous immunoglobulin for the secondary prevention of stillbirth in obstetric antiphospholipid syndrome: A case series and systematic review of literature 222
Thrombosis in Autoimmune Diseases: A Role for Immunosuppressive Treatments? 221
First report of FIP1L1-PDGFR alpha-positive eosinophilic granulomatosis with polyangiitis 220
Thrombosis in vasculitis: from pathogenesis to treatment 211
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 208
Intravenous immunoglobulin therapy: a snapshot for the internist. 208
A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies 203
Behçet's syndrome as a tool to dissect the mechanisms of thrombo-inflammation: clinical and pathogenetic aspects 203
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 203
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 202
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes 201
Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-α in early phases of the disease 200
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 200
Long-term effectiveness and safety of secukinumab for treatment of refractory mucosal and articular Behçet's phenotype: A multicentre study 200
Pharmacological prevention of venous thromboembolism in orthopaedic surgery 199
Stem-Cell-Derived Circulating Progenitors Dysfunction in Behçet's Syndrome Patients Correlates With Oxidative Stress 199
Prevalence and clinical associations of ultrasound-confirmed enthesitis in systemic lupus erythematosus 196
A unique circulating miRNA profile highlights thrombo-inflammation in Behçet's syndrome 196
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 192
Thrombosis in inflammatory bowel diseases: What's the link? 191
Belimumab reduces antiphospholipid antibodies in SLE patients independently of hydroxychloroquine treatment 191
Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre 190
Systemic lupus erythematosus: immunopathogenesis and novel therapeutic targets 189
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 188
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement 188
Interleukin-17/Interleukin-21 and Interferon-g producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome 187
Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset still's disease: A multicentre retrospective observational study 186
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 184
Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European multicenter observational study 184
Comparison of treatments for the prevention of fetal growth restriction in obstetric antiphospholipid syndrome: a systematic review and network meta-analysis 184
Non-anti TNFα biologic agents for noninfectious uveitis associated with systemic inflammatory diseases: a systematic review 181
Pathogenesis of Behcet Syndrome 181
Redox status alterations during the competitive season in élite soccer players: focus on peripheral leukocyte-derived ROS 180
Rapid desensitization to anakinra-related delayed reaction: Need for a standardized protocol 180
β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome 179
Secukinumab reduces plasma oxidative stress in psoriasis: A case-based experience 177
Impact of cardiovascular and immunologic variables on subclinical carotid atherosclerosis in subjects with anti-phospholipid antibodies 177
Susceptibility weighted MRI can help differentiating pathogenesis of white matter lesions in MS and CNS inflammatory vasculopathies. 176
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 176
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 175
MRI evaluation of the "central vein sign" in brain white matter lesions of multiple sclerosis and systemic autoimmune diseases. 174
Circulating miRNome profiling data in Behçet's syndrome 173
CSF/serum matrix metallopeptidase‐9 ratio discriminates neuro Behçet from multiple sclerosis 172
Prognostic Value of Degree and Types of Anaemia on Clinical Outcomes for Hospitalised Older Patients 171
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 171
Anakinra for resistant Behçet uveitis: why not? 170
What changed in the Italian internal medicine and geriatric wards during the lockdown 170
Behçet's syndrome pathophysiology and potential therapeutic targets 170
Differential Diagnosis 169
POS1212 SARS-CoV-2 INFECTION AMONG PATIENTS WITH BEHÇET’S SYNDROME 169
Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside 169
Neutrophil-mediated mechanisms of damage and in vitro protective effect of colchicine in non-vascular Behçet's syndrome 168
Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study 163
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: analysis of the REPOSI registry 162
Gut Microbiota and Associated Mucosal Immune Response in Eosinophilic Granulomatosis with Polyangiitis (EGPA) 161
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 159
Imaging perivenular distribution can differentiate MS from CNS vasculitis. 158
Reply: anti-IL1 blocking agents in drug-resistant Behçet's syndrome: our little case series 158
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 157
A multicenter approach to evaluate omalizumab effectiveness in Samter's triad 156
Microparticles: Bridging the gap between autoimmunity and thrombosis 155
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome 155
The right place of interleukin-1 inhibitors in the treatment of Behçet’s syndrome: a systematic review 153
Favorable pregnancy outcome in a patient with systemic lupus erythematosus treated with belimumab: A confirmation report 153
Efficacy of the anti-IL 17 secukinumab in refractory Behçet's syndrome: A preliminary study 150
Novel oral anticoagulants in Atrial fibrillation: Which novel oral anticoagulant for which patient? 149
Vascular Behçet's syndrome: an update 148
Behçet's disease as a cause of cerebral sinus vein thrombosis: an emerging role 148
Sharing data of clinical trials 147
null 146
Pathogenesis of Behcet Syndrome 145
Rare NLRP12 variants associated with the NLRP12-autoinflammatory disorder phenotype: an Italian case series 145
Serum Interleukin-36 α as a Candidate Biomarker to Distinguish Behçet’s Syndrome and Psoriatic Arthritis 144
HELICOBACTER PYLORI HP0175 PROMOTES THE PRODUCTION OF IL-23, IL-6, IL-1 beta AND TGF-beta 144
Obstetric antiphospholipid syndrome is not associated with an increased risk of subclinical atherosclerosis 144
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study 143
The association of adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) with cardiovascular disease in subjects with antiphospholipid antibodies 143
The "multifaceted" onset of vasculitis neuropathy 143
Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis 141
Pulmonary fibrosis and lymphocytic alveolitis associated with triple antiphospholipid antibody positivity: a diagnostic puzzle. 141
Efficacy and Safety of Intravenous Immunoglobulin Treatment in Refractory Behcet's Disease with Different Organ Involvement: A Case Series 140
Efficacy and safety profile of anti-interleukin-1 treatment in Behçet's disease: a multicenter retrospective study 140
A new case of idiopathic recurrent acute pericarditis due to R104Q mutation in TNFRSF1A successfully treated with anakinra: expanding the questions 140
Totale 19.302
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.754
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.754
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.006 37 43 125 38 29 71 29 100 62 42 167 263
2022/20232.402 206 516 142 108 118 384 339 136 248 31 71 103
2023/20241.126 40 101 160 55 79 223 37 175 36 71 73 76
2024/20256.769 274 680 368 1.187 1.818 784 137 368 299 262 309 283
2025/20267.867 868 948 617 868 844 322 876 336 425 534 244 985
2026/202727 27 0 0 0 0 0 0 0 0 0 0 0
Totale 23.786